Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

ABVC BioPharma (ABVC) News Today

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free ABVC Stock Alerts
$1.07
+0.01 (+0.94%)
(As of 05/17/2024 08:53 PM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
May 17 at 11:32 PM | investorplace.com
ABVC Stock Earnings: ABVC BioPharma Reported Results for Q1 2024
May 15, 2024 | finance.yahoo.com
Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50M
May 15, 2024 | americanbankingnews.com
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 19.6% in April
May 9, 2024 | finance.yahoo.com
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
April 26, 2024 | finance.yahoo.com
ABVC BioPharma, Inc. (ABVC)
April 18, 2024 | investing.com
ABVC BioPharma inks licensing deal for cancer drug
April 18, 2024 | finanznachrichten.de
ABVC BioPharma, Inc.: AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
April 18, 2024 | globenewswire.com
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
April 17, 2024 | markets.businessinsider.com
ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404
April 17, 2024 | finance.yahoo.com
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
April 17, 2024 | globenewswire.com
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
April 10, 2024 | globenewswire.com
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
March 28, 2024 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
March 27, 2024 | msn.com
Why ABVC BioPharma Stock Is Up Today
March 26, 2024 | markets.businessinsider.com
ABVC Announces Global Licensing Deal With ForSeeCon Eye For Vitargus
March 26, 2024 | globenewswire.com
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
March 21, 2024 | finance.yahoo.com
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
March 19, 2024 | ca.finance.yahoo.com
ABVC BioPharma, Inc. (ABVC) Interactive Stock Chart - Yahoo Finance
March 19, 2024 | globenewswire.com
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
March 14, 2024 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
March 14, 2024 | globenewswire.com
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
February 27, 2024 | finance.yahoo.com
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
February 15, 2024 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
February 15, 2024 | markets.businessinsider.com
ABVC Signes Agreement To License Its 'Know-How' To SPI
February 15, 2024 | finance.yahoo.com
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
February 15, 2024 | globenewswire.com
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
February 12, 2024 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
February 12, 2024 | markets.businessinsider.com
ABVC BioPharma Receives Australian Patent For PDC-1421 For Treatment Of MDD
February 12, 2024 | finance.yahoo.com
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
February 9, 2024 | msn.com
ABVC BioPharma Conducts Private Equity and Warrants Sale
February 9, 2024 | msn.com
ABVC BioPharma Expands Footprint with Strategic Land Acquisitions
January 25, 2024 | benzinga.com
Looking Into ABVC BioPharma's Recent Short Interest
January 12, 2024 | msn.com
ABVC BioPharma files to sell 10.4M shares for holders
January 3, 2024 | msn.com
Why Is Plant-Based Medications-Focused ABVC BioPharma Stock Trading Higher Today?
January 3, 2024 | markets.businessinsider.com
ABVC BioPharma Reports Milestone Payment From From AiBtl BioPharma; AiBtl Becomes Subsidiary
January 3, 2024 | marketwatch.com
ABVC BioPharma Shares Jump 73% After Milestone Payment
January 3, 2024 | msn.com
ABVC Biopharma and unit receive $460M as first milestone payment; shares jump
December 7, 2023 | finance.yahoo.com
ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study
December 5, 2023 | finance.yahoo.com
ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials
November 21, 2023 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
November 21, 2023 | marketwatch.com
ABVC BioPharma Shares Rise 11% After U.S. Patent for ADHD Treatment
November 21, 2023 | finance.yahoo.com
ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
November 16, 2023 | markets.businessinsider.com
ABVC BioPharma Enters Into Global LIcensing Agreement With AiBtl
November 16, 2023 | finance.yahoo.com
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
November 15, 2023 | finanznachrichten.de
ABVC BioPharma, Inc.: ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
November 15, 2023 | msn.com
ABVC BioPharma GAAP EPS of -$0.82, revenue of $0.02M
November 15, 2023 | finance.yahoo.com
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
October 27, 2023 | benzinga.com
What's Going On With ABVC Biopharma Stock Friday?
October 26, 2023 | marketwatch.com
Health Care Down Amid Mixed Earnings -- Health Care Roundup
October 26, 2023 | benzinga.com
What In The World Is Going On With ABVC BioPharma Stock?
Get ABVC BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter.

He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)

For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.

Click for his six specific AI stock in the crosshairs

ABVC Media Mentions By Week

ABVC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABVC
News Sentiment
▼
-0.42

0.42
▲
Average
Medical
News Sentiment

ABVC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABVC Articles
This Week
▼
4

1
▲
ABVC Articles
Average Week

Get ABVC BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ABVC) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders